Advanced Biomed (ADVB) Long-Term Deferred Tax (2024 - 2026)

Advanced Biomed has reported Long-Term Deferred Tax for 3 years, with the latest figure at $1.8 million in Q1 2026.

• Quarterly Long-Term Deferred Tax changed N/A year-over-year to $1.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.8 million (changed N/A YoY) and the FY2025 annual result came in at $1.7 million, up 159.66% from the prior year.
• Long-Term Deferred Tax improved to $1.8 million in Q1 2026 per ADVB's latest filing, from $1.7 million in the prior quarter.
• Over five years, Long-Term Deferred Tax peaked at $1.8 million in Q1 2026 and troughed at $638871.0 in Q2 2024.
• A 3-year average of $1.2 million and a median of $1.2 million in 2024 frame the typical range for Long-Term Deferred Tax.
• The widest YoY moves for Long-Term Deferred Tax: up 159.66% in 2025, down 159.66% in 2025.
• Over 3 years, Long-Term Deferred Tax stood at $672471.0 in 2024, then soared by 146.68% to $1.7 million in 2025, then gained by 6.75% to $1.8 million in 2026.
• According to Business Quant data, Long-Term Deferred Tax over the past three periods registered $1.8 million, $1.7 million, and $672471.0 for Q1 2026, Q2 2025, and Q4 2024 respectively.